Breaking News

Blue Stream Labs Adds Personnel and Mass Spec Systems

February 14, 2013

Stephens, Li bring extensive mass spec experience

Blue Stream Laboratories has enhanced its Mass Spectrometry (MS) capabilities with the addition of two new personnel and instrumentation. Elaine Stephens, Ph.D., has been appointed to head Blue Stream’s Cambridge, MA-based MS lab, which provides analytical expertise from pre-IND through cGMP clinical phase product development.
 
Dr. Stephens has more than 15 years of experience as head of Mass Spectrometry. She has in-depth expertise in protein characterization using mass spectrometry, with extensive knowledge in glycoprotein structure elucidation. Before joining the company, she spent many years as head of Mass Spectrometry at MRC Laboratory of Molecular Biology and the Chemistry Department at Cambridge University. Additionally, she has authored and co-authored more than 40 peer-reviewed publications.
 
Jing Li, Ph.D. joined Blue Stream as a scientist for mass spectrometry characterization. Dr. Li gained extensive experience in mass spectrometry and glycomics at MIT, where she helped to develop glycan-based vaccines and therapeutics.  
 
Additionally, the company’s MS facility recently added two new mass spectrometer systems, the Agilent 6538 QTOF, which significantly improves the lab's data quality and sample throughput, and the Thermo TSQ Vantage Triple Stage Quadrupole, which provides capabilities for quantitative analysis of biosimilars, peptides, and other biologics.
 
Michael Kouchakdjian, Ph.D., president of Blue Stream Laboratories, said, "Our clients tell us that they come to Blue Stream for our unmatched expertise and speed in characterizing their complex biologics. Our methods and personnel allow us to provide high quality data coupled with in-depth interpretation, enabling clients to make better-informed decisions more quickly and with greater confidence as they advance their development programs."

blog comments powered by Disqus
  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important

  • Moore’s Law for More Health

    Moore’s Law for More Health

    Patrick Jordan , Encore Health Resources||June 2, 2015
    This year marks the semicentennial anniversary of a prediction about exponential growth and productivity